Acute alveolitis following infliximab therapy for psoriasis

Australasian Journal of Dermatology

Volumn 54, Issue 1, 2013, Pages 61-63

  Bale, Jessica ^a   Chee, Paul ^a  

^a JOHN HUNTER HOSPITAL   (Australia)

Author keywords

alveolitis; infliximab; interstitial lung disease; psoriasis; tumour necrosis factor inhibitor

Indexed keywords

AZITHROMYCIN; CALCIPOTRIOL; COTRIMOXAZOLE; CYCLOSPORIN; ETRETIN; HYDROCORTISONE; IMMUNOGLOBULIN G1; INFLIXIMAB; METHOTREXATE; PENICILLIN G; PREDNISONE; TIMENTIN;

ADD ON THERAPY; AGED; ANTIBIOTIC THERAPY; ARTERIAL GAS; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; COUGHING; DRUG WITHDRAWAL; DYSPNEA; EMERGENCY WARD; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG ALVEOLITIS; MALE; OXYGEN SATURATION; PNEUMONIA; PSORIASIS; PSORIASIS VULGARIS; RESPIRATORY FAILURE; THORAX RADIOGRAPHY; ULTRAVIOLET B RADIATION;

AGED; ANTIBODIES, MONOCLONAL; DERMATOLOGIC AGENTS; HUMANS; MALE; PNEUMONIA; PSORIASIS; PULMONARY ALVEOLI;

EID: 84873408055     PISSN: 00048380     EISSN: 14400960     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2012.00924.x     Document Type: Article

References (14)

1. Brimhall AK, Licciardone JC, Jacobe H, et al. Safety and efficacy of alefacept, efalizumab, etanercept and infliximab in treating moderate to severe plaque psoriasis: a meta-analysis of randomized controlled trials. Br. J. Dermatol. 2008; 159: 274-285.
2. Takeuchi T, Tatsuki Y, Nogami Y, et al. Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis. Ann. Rheum. Dis. 2008; 67: 189-194.
3. Australian Government Department of Health and Ageing, Office of Product Review. Australian database of suspected adverse reactions to drugs: medicine summary for infliximab. Available from Office of Product Review, URL: http://www.tga.gov.au. ((extracted 13 Jan 2012).
4. Khasnis AA, Calabrese LH,. Tumour necrosis factor inhibitors and lung disease: a paradox of efficacy and risk. Semin. Arthritis Rheum. 2010; 40: 147-163.
5. Courtney PA, Alderdice J, Whitehead EM, et al. Comment on methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis. Arthritis Rheum. 2003; 49: 617-618, author reply.
6. Kramer N, Chuzhin Y, Kaufman LD, et al. Methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis. Arthritis Rheum. 2002; 47: 670-671.
7. Östor AJ, Chilvers ER, Somerville MF, et al. Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis. J. Rheumatol. 2006; 33: 622-628.
8. El-Hag K, Dercken HG, Prenzel R, et al. Drug-induced alveolitis associated with infliximab/azathioprine therapy. Pneumologie 2008; 62: 204-208.
9. Hirofumi T, Kawagishi Y, Shinoda K, et al. Interstitial pneumonitis with infliximab therapy without methotrexate treatment. Rheumatol. Int. 2009; 30: 275-276.
10. Braun J, Brandt J, Listing J, et al. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 2002; 359: 1187-1193.
11. Pataka A, Tzouvelekis A, Bouros D,. Infliximab-induced non-specific interstitial pneumonia and lupus-like eruption. Eur. J. Intern. Med. 2006; 17: 520.
12. Veerappan SG, O'Morain CA,. Infliximab-associated alveolitis after treatment for severe left-sided ulcerative colitis. Eur. J. Gastrodnterol. Hepatol. 2009; 21: 830-832.
13. Leger S, Etienne M, Duval-Modeste AB, et al. Interstitial pneumonia after infliximab therapy for psoriasis. Ann. Dermatol. Venereol. 2011; 138: 499-503.
14. Ramos-Casals M, Perez-Alvarez R, Perez-de-lis M, et al. Pulmonary disorders induced by monoclonal antibodies in patients with rheumatologic autoimmune diseases. Am. J. Med. 2011; 124: 386-394.